Beijing Hotgen Biotech Co Ltd (688068) — Financial Flexibility Index
Beijing Hotgen Biotech Co Ltd (688068) has a Financial Flexibility Index of 0.06x as of September 2025. Free cash flow of CN¥17.78 Million (operating CF CN¥3.05 Million minus capex CN¥14.73 Million) represents 0% of total liabilities (CN¥278.25 Million). Also explore Beijing Hotgen Biotech Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Beijing Hotgen Biotech Co Ltd Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Beijing Hotgen Biotech Co Ltd across 9 annual periods. Check Beijing Hotgen Biotech Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Beijing Hotgen Biotech Co Ltd (2016–2024)
Year-by-year free cash flow to debt coverage for Beijing Hotgen Biotech Co Ltd. For the full company profile including market capitalisation, see market value of Beijing Hotgen Biotech Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.06x | CN¥14.24 Million | CN¥-37.16 Million | CN¥251.77 Million | ▼ -97.0% |
| 2023 | 1.92x | CN¥387.98 Million | CN¥-25.39 Million | CN¥202.56 Million | ▼ -32.3% |
| 2022 | 2.83x | CN¥1.54 Billion | CN¥978.75 Million | CN¥545.59 Million | ▼ -28.3% |
| 2021 | 3.95x | CN¥3.04 Billion | CN¥2.64 Billion | CN¥771.01 Million | ▲ +82.5% |
| 2020 | 2.16x | CN¥336.89 Million | CN¥164.62 Million | CN¥155.72 Million | ▲ +53.2% |
| 2019 | 1.41x | CN¥107.86 Million | CN¥19.37 Million | CN¥76.37 Million | ▼ -17.5% |
| 2018 | 1.71x | CN¥97.04 Million | CN¥55.04 Million | CN¥56.68 Million | ▼ -47.9% |
| 2017 | 3.29x | CN¥92.00 Million | CN¥22.95 Million | CN¥28.00 Million | ▲ +43.5% |
| 2016 | 2.29x | CN¥66.72 Million | CN¥45.54 Million | CN¥29.14 Million | — |